Insulin glargine 300 U/mL safety data in pregnancy

被引：0
|
作者：
Westerbacka, Jukka [1 ]
Duverne, Marielle [1 ]
Grulovic, Natasa [1 ]
Thummisetti, Sreenivas [2 ]
Doder, Zoran [3 ]
机构：
[1] Sanofi, 46 Ave Grande, F-75017 Paris, France
[2] Sanofi, Hyderabad, India
[3] Sanofi, Bridgewater, MA USA
来源：
DIABETES OBESITY & METABOLISM | 2025年 / 27卷 / 05期
关键词：
gestational diabetes; glycaemic control; hypoglycaemia; insulin glargine; pregnancy; GLYCEMIC CONTROL; PERINATAL OUTCOMES; RANDOMIZED-TRIAL; ASPART; WOMEN; PROVIDES; DEGLUDEC; DETEMIR;
D O I：
10.1111/dom.16295
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2322 / 2325
页数：4
相关论文
共 50 条
  • [31] Comparison of pharmacodynamics and pharmacokinetics of insulin degludec and insulin glargine 300 U/mL in healthy cats
    Gilor, C.
    Culp, W.
    Ghandi, S.
    do Carmo Emidio e Silva, J. A.
    Ladhar, A.
    Hulsebosch, S.
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2019, 69 : 19 - 29
  • [32] Switching to insulin glargine 300 U/mL: Is duration of prior basal insulin therapy important?
    Bonadonna, Riccardo C.
    Renard, Eric
    Cheng, Alice
    Fritsche, Andreas
    Cali, Anna
    Melas-Melt, Lydie
    Umpierrez, Guillermo E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 142 : 19 - 25
  • [33] PREDICTION OF HYPOGLYCEMIA IN PATIENTS TREATED WITH INSULIN GLARGINE 300 U/ML FOR BASAL INSULIN THERAPY
    Takeishi, S.
    Inoue, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A176 - A177
  • [34] Insulin glargine 300 U/ml versus Insulin degludec 100 U/ml Direct Comparison of long-acting Insulins
    Stiefelhagen, Peter
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2019, 12 (01): : 38 - 38
  • [35] COMPARISON OF INSULIN GLARGINE 300 U/ML, INSULIN DEGLUDEC AND INSULIN GLARGINE 100 U/ML, IN BASAL INSULIN THERAPY USING FREESTYLE LIBRE PRO: RANDOMISED TRIPLE CROSSOVER STUDY
    Takeishi, S.
    Tsuboi, H.
    Takekoshi, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A137 - A137
  • [36] Insulin Glargine 300 U/mL Therapy in Children and Adolescents with Type 1 Diabetes
    Maffeis, Claudio
    Rabbone, Ivana
    PEDIATRIC DRUGS, 2022, 24 (05) : 499 - 512
  • [37] INSULIN GLARGINE 300U/ML AND INSULIN GLARGINE 100U/ML SHOW EQUIPOTENT IN VIVO BLOOD GLUCOSE LOWERING WHEN ADMINISTERED INTRAVENOUSLY IN DOGS
    Werner, U.
    Korn, M.
    Tennagels, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A119 - A119
  • [38] Insulin Glargine 300 U/mL Therapy in Children and Adolescents with Type 1 Diabetes
    Claudio Maffeis
    Ivana Rabbone
    Pediatric Drugs, 2022, 24 : 499 - 512
  • [39] Pharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevance
    Owens, David R.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (08) : 977 - 987
  • [40] THE REAL-WORLD DOSE DIFFERENCES OF INSULIN GLARGINE 300 U/ML IN FINLAND
    Koski, L.
    Hahl, J.
    Kaye, S.
    Pousar, K.
    VALUE IN HEALTH, 2019, 22 : S596 - S596
12345